FoxO1 up-regulation was associated with enhanced autophagic activity and pathological changes of muscle fibers in FHL1 KO mice, which indicated the activation of autophagy by FoxO1, and therefore represents a promising therapeutic target for hereditary myopathies and cardiomyopathies induced by FHL1. This evidence concerns the gene FOXO1 and cardiomyopathy.